UroMed Corporation Complies With Nasdaq SmallCap Market Continued Listing Requirements.NORWOOD, Mass.--(BUSINESS WIRE)--Nov. 10, 1998--UroMed Corporation's (the "Company") was notified by Nasdaq of its compliance with all requirements set forth by the Nasdaq Listing Qualifications Panel necessary for continued listing on the Nasdaq SmallCap Market. The Company had been listed on the Nasdaq SmallCap Market on a temporary status via an exception to continued listing requirements Listing requirements Requirements, including minimum shares outstanding, market value, and income, that are laid down by an exchange for any stock to be listed for trading. . Accordingly, the Company's securities will continue to be listed on the Nasdaq SmallCap Market and the symbol has been changed from URMDC back to URMD. Additionally, the Company announced that it has moved its corporate headquarters to 1400 Providence Highway, Building 2, Norwood, MA 02062. UroMed, founded in October 1990, is dedicated to establishing itself as a leader in the development of male and female healthcare products. UroMed has developed or acquired technology in three core areas: prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. , urinary incontinence, and breast cancer. UroMed's direct hospital-based business lines include its CaverMap Surgical Aid, intended to aid physicians in preserving vital nerves during prostate cancer surgery, its Iodine125 prostate cancer brachytherapy seeds (not yet commercially available), its brachytherapy introducer needles, and AlloSling and BEACON Technology System, minimally invasive incontinence surgical lines. UroMed's office-based continuum of continence continence /con·ti·nence/ (kon´tin-ens) the ability to control natural impulses.con´tinent con·ti·nence n. 1. Self-restraint; moderation. 2. care product lines include the Reliance(R) Insert, the INTROL(R) Bladder Neck Support Prosthesis prosthesis (prŏs`thĭsĭs): see artificial limb. prosthesis Artificial substitute for a missing part of the body, usually an arm or leg. , and the Impress Softpatch, for which the company is seeking marketing partnership(s). In breast cancer screening This article or section recently underwent a major revision or rewrite and needs further review. You can help! X-ray mammography Mammography is still the modality of choice for screening of early breast cancer, since it is relatively fast, reasonably accurate, and , UroMed, through its Assurance Medical group, is developing its investigational BreastExam(tm), BreastCheck(tm) and BreastView(tm) electronic palpation palpation /pal·pa·tion/ (pal-pa´shun) the act of feeling with the hand; the application of the fingers with light pressure to the surface of the body for the purpose of determining the condition of the parts beneath in physical diagnosis. technology in order to aid physicians and patients in the important mission of finding suspicious breast lumps earlier. UroMed also continues to dedicate resources to the development and/or acquisition of product lines that fit into UroMed's strategic platform. INTROL(R) Bladder Neck Support Prosthesis and Reliance(R) Urinary Control Insert are registered trademarks of UroMed Corporation. Impress(tm)Softpatch, PelvicFlex(tm) Personal Trainer Video , BEACON Technology System(tm), BreastCheck(tm) BreastExam(tm) BreastView(tm), CaverMap(tm) Surgical Aid and AlloSling(tm) Fascia fascia (făsh`ēə), fibrous tissue network located between the skin and the underlying structure of muscle and bone. Fascia is composed of two layers, a superficial layer and a deep layer. are trademarks of UroMed Corporation. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion